Search Results - "Sousa, Elsa Joana"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3 by Vieira, Filipa Quintela, Costa-Pinheiro, Pedro, Almeida-Rios, Diogo, Graça, Inês, Monteiro-Reis, Sara, Simões-Sousa, Susana, Carneiro, Isa, Sousa, Elsa Joana, Godinho, Maria Inês, Baltazar, Fátima, Henrique, Rui, Jerónimo, Carmen

    Published in Oncotarget (30-05-2015)
    “…Prostate cancer (PCa) is one of the most incident cancers worldwide but clinical and pathological parameters have limited ability to discriminate between…”
    Get full text
    Journal Article
  3. 3

    Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells by Graça, Inês, Sousa, Elsa J, Baptista, Tiago, Almeida, Mafalda, Ramalho-Carvalho, João, Palmeira, Carlos, Henrique, Rui, Jerónimo, Carmen

    Published in Current pharmaceutical design (01-04-2014)
    “…Current therapeutic strategies for advanced prostate cancer (PCa) are largely ineffective. Because aberrant DNA methylation associated with inappropriate…”
    Get more information
    Journal Article
  4. 4

    Anti-neoplastic properties of hydralazine in prostate cancer by Graça, Inês, Sousa, Elsa J, Costa-Pinheiro, Pedro, Vieira, Filipa Q, Torres-Ferreira, Jorge, Martins, Maria Gabriela, Henrique, Rui, Jerónimo, Carmen

    Published in Oncotarget (15-08-2014)
    “…Prostate cancer (PCa) is a major cause of cancer-related morbidity and mortality worldwide. Although early disease is often efficiently managed…”
    Get full text
    Journal Article
  5. 5

    Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing by Sousa, Elsa J., Graça, Inês, Baptista, Tiago, Vieira, Filipa Q., Palmeira, Carlos, Henrique, Rui, Jerónimo, Carmen

    Published in Epigenetics (01-05-2013)
    “…Prostate cancer (PCa) is one of the most incident malignancies worldwide. Although efficient therapy is available for early-stage PCa, treatment of advanced…”
    Get full text
    Journal Article
  6. 6

    Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer by Baptista, Tiago, Graça, Inês, Sousa, Elsa J, Oliveira, Ana I, Costa, Natália R, Costa-Pinheiro, Pedro, Amado, Francisco, Henrique, Rui, Jerónimo, Carmen

    Published in Oncotarget (01-10-2013)
    “…Histone variants seem to play a major role in gene expression regulation. In prostate cancer, H2A.Z and its acetylated form are implicated in oncogenes'…”
    Get full text
    Journal Article
  7. 7

    Assessment of Enoxacin Effect on Cancer Growth and Microrna Expression in Prostate Cell Lines by Sousa, Elsa Joana Ferreira de

    Published 01-01-2012
    “…Background: Prostate cancer (PCa) is one of the most incident malignancies worldwide and represents a leading cause of cancer-related morbidity and…”
    Get full text
    Dissertation